John J. Canepa's most recent trade in Candel Therapeutics Inc was a trade of 110,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 28, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Candel Therapeutics Inc | John J. Canepa | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | John J. Canepa | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 29 Jul 2021 | 10,125 | 10,125 | - | 8 | 81,000 | Common Stock |